Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000559916 | SCV000656023 | likely benign | Noonan syndrome 9 | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001251388 | SCV001426971 | likely benign | not specified | 2020-07-13 | criteria provided, single submitter | clinical testing | Variant summary: SOS2 c.3088A>G (p.Thr1030Ala) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 240566 control chromosomes. The observed variant frequency is approximately 75 fold of the estimated maximal expected allele frequency for a pathogenic variant in SOS2 causing Noonan Syndrome And Related Conditions phenotype (2.5e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.3088A>G in individuals affected with Noonan Syndrome And Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. |
Ambry Genetics | RCV002325091 | SCV002608742 | likely benign | Cardiovascular phenotype | 2022-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000559916 | SCV002763008 | likely benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Ce |
RCV003392402 | SCV004134077 | benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | SOS2: BS1, BS2 |
Breakthrough Genomics, |
RCV003392402 | SCV005211995 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Service de Génétique Moléculaire, |
RCV001261127 | SCV001438534 | likely benign | Noonan syndrome | no assertion criteria provided | clinical testing |